TrialAmerican journal of cardiovascular drugs : drugs, devices, and other interventions2026

Safety and Short-Term Effects of Empagliflozin in Patients with Heart Failure and End-Stage Renal Disease.

Donna Shu-Han Lin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.